TK cell therapy (Binex)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTK cell therapy (Binex)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapyCell and gene therapy > Gene therapy
Mechanisms of ActionThymidine kinase modulators
TargetsThymidine kinase
Therapy Area/IndicationsStomach NeoplasmsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBinex
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBinex
Active IndicationsN/A
Inactive IndicationsStomach NeoplasmsColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A